June 30, 2025

News

NRx Pharmaceuticals (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100✎ Contributed by Ty Griffin The new FDA voucher program aims to speed approval of drugs aligned...
NRx Pharmaceuticals (NASDAQ: NRXP) Subsidiary HOPE Therapeutics to Acquire 49% Stake in Leading Florida Psychiatry Clinic✎ Contributed by Ty Griffin NRx Pharmaceuticals (NASDAQ: NRXP), via its wholly owned subsidiary HOPE Therapeutics(TM), Inc.,...